Tag archive for ‘Sound Pharmaceuticals’
Sound Pharmaceuticals gets NIH grant for testing Covid-19 candidate SPI-1005 in phase 2 trials.
By businessnewstoday On Tuesday, April 6th, 2021

Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005

Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials from the National Center for Advancing Translational More...

By pharmanewsdaily On Wednesday, September 18th, 2019

Sound Pharmaceuticals bags FDA fast track status for SPI-1005 in Meniere’s Disease

US biopharma company Sound Pharmaceuticals said that its investigational drug SPI-1005 has secured the fast track designation (FTD) from the US Food and Drug Administration (FDA) for the treatment of Meniere’s More...